Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 5
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Tolfine 40 mg/ml V/NRP/08/1583 Vetoquinol S.A., Francija QM01AG02 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tolfenamic acid
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Vetoquinol Biowet Sp. z o.o., Polija;Vetoquinol S.A., Francija
Date of authorisation/renewal: 22-Sep-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Mar-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Mar-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/08/1583-01 40 mg/ml 1 Flakons, 100 ml -
V/NRP/08/1583-02 40 mg/ml 1 Flakons, 50 ml -
V/NRP/08/1583-03 40 mg/ml 1 Flakons, 250 ml -
Bovilis Rotavec Corona - V/MRP/08/0002 Intervet International B.V., Nīderlande QI02AL01 cattle Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Bovine coronavirus, strain Mebus, Inactivated, Bovine rotavirus, strain UK-Compton, Inactivated, E. coli F5 (K99) adhesin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 09-Jul-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Jul-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Jul-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/0002-01 10 Stikla flakons, 2 ml -
V/MRP/08/0002-02 1 Stikla flakons, 10 ml -
V/MRP/08/0002-03 1 Stikla flakons, 40 ml -
V/MRP/08/0002-04 1 Stikla flakons, 100 ml -
V/MRP/08/0002-05 1 PET flakons, 10 ml -
V/MRP/08/0002-06 1 PET flakons, 40 ml -
V/MRP/08/0002-07 1 PET flakons, 100 ml -
Duplocillin LA - V/NRP/96/0457 Intervet International B.V., Nīderlande QJ01CR50 cattle; pigs; sheep; horses; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Benzathine benzylpenicillin, Procaine benzylpenicillin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Aprilia Animal Health S.r.l., Itālija
Date of authorisation/renewal: 17-Nov-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-May-2026)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0457-01 1 Stikla flakons, 100 ml -
V/NRP/96/0457-02 1 Stikla flakons, 250 ml -
V/NRP/96/0457-03 1 PET flakons, 100 ml -
V/NRP/96/0457-04 1 PET flakons, 250 ml -
Metrobactin vet 250 mg V/DCP/15/0054 Dechra Regulatory B.V., Nīderlande QP51AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 21-Dec-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0054-01 250 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-02 250 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-03 250 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-04 250 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-05 250 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-06 250 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-07 250 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-08 250 mg 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-09 250 mg 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-10 250 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-11 250 mg 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-12 250 mg 50 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0054-13 250 mg 10 Kastīte ar blisteri, 10 tablete -
V/DCP/15/0054-14 250 mg 10 Kastīte ar blisteri, 100 tablete -
Metrobactin vet 500 mg V/DCP/15/0055 Dechra Regulatory B.V., Nīderlande QP51AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 21-Dec-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0055-01 500 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-02 500 mg 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-03 500 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-04 500 mg 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-05 500 mg 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-06 500 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-07 500 mg 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-08 500 mg 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-09 500 mg 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-10 500 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-11 500 mg 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-12 500 mg 50 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/15/0055-13 500 mg 10 Kastīte ar blisteri, 10 tablete -
V/DCP/15/0055-14 500 mg 10 Kastīte ar blisteri, 100 tablete -
Canizol vet 200 mg V/DCP/14/0052 Dechra Regulatory B.V., Nīderlande QJ02AB02 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Ketoconazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 01-Aug-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0052-01 200 mg 1 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-02 200 mg 2 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-03 200 mg 3 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-04 200 mg 4 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-05 200 mg 5 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-06 200 mg 6 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-07 200 mg 7 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-08 200 mg 8 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-09 200 mg 9 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0052-10 200 mg 10 PVH/PVDH alumīnija blisteris, 10 tablete -
Canizol vet 400 mg V/DCP/14/0053 Dechra Regulatory B.V., Nīderlande QJ02AB02 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Ketoconazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 01-Aug-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (25-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0053-01 400 mg 1 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-02 400 mg 2 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-03 400 mg 3 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-04 400 mg 4 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-05 400 mg 5 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-06 400 mg 6 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-07 400 mg 7 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-08 400 mg 8 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-09 400 mg 9 PVH/PVDH alumīnija blisteris, 10 tablete -
V/DCP/14/0053-10 400 mg 10 PVH/PVDH alumīnija blisteris, 10 tablete -
Pyrocam 15 mg/ml V/DCP/23/0049 Huvepharma NV, Beļģija QM01AC06 pigs Vairāk

Medicinal product information

Pharmaceutical form: Oral suspension
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet JSC, Bulgārija
Date of authorisation/renewal: 18-Sep-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Sep-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0049-01 15 mg/ml 1 ABPE pudele, 125 ml -
V/DCP/23/0049-02 15 mg/ml 1 ABPE pudele, 250 ml -
V/DCP/23/0049-03 15 mg/ml 1 ABPE pudele, 1000 ml -
Cevac Transmune - V/MRP/13/0036 Ceva Sante Animale., Francija QI01AD09 chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Avian infectious bursal disease virus Winterfield 2512, G-61 strain
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal: 09-Dec-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 200421_LI (20-Apr-2021)
Labelling text: [DOC] 200421_M (20-Apr-2021)
Summary of product characteristics: [DOCX] 200421_ZA (20-Apr-2021)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0036-01 20 Stikla flakons, 2000 deva -
V/MRP/13/0036-02 20 Stikla flakons, 2500 deva -
V/MRP/13/0036-03 20 Stikla flakons, 4000 deva -
V/MRP/13/0036-04 20 Stikla flakons, 5000 deva -
V/MRP/13/0036-05 20 Stikla flakons, 8000 deva -
V/MRP/13/0036-06 1 Stikla flakons, 2000 deva -
V/MRP/13/0036-07 1 Stikla flakons, 2500 deva -
V/MRP/13/0036-08 1 Stikla flakons, 4000 deva -
V/MRP/13/0036-09 1 Stikla flakons, 5000 deva -
V/MRP/13/0036-10 1 Stikla flakons, 8000 deva -
Api-Bioxal 886 mg/g V/MRP/21/0019 Chemicals Laif S.p.A., Itālija QP53AG03 honey bees Vairāk

Medicinal product information

Pharmaceutical form: Powder for in-hive use
International name (active substance): Oxalic acid dihydrate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chemifarma S.p.A., Itālija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 230321M+LI (23-Mar-2021)
Labelling text: [DOCX] 230321M+LI (23-Mar-2021)
Summary of product characteristics: [DOCX] 230321ZA (23-Mar-2021)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0019-01 886 mg/g 1 iepakojums, 35 g -
V/MRP/21/0019-02 886 mg/g 1 iepakojums, 175 g -
V/MRP/21/0019-03 886 mg/g 1 iepakojums, 350 g -
Elivex 5 mg/ml V/DCP/18/0006 Industrial Veterinaria, S.A., Spānija QP54AA04 cattle; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: Pour-on solution
International name (active substance): Eprinomectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Industrial Veterinaria, S.A., Spānija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0006-01 1 ABPE pudele, 1 l -
V/DCP/18/0006-02 1 ABPE pudele, 2,5 l -
V/DCP/18/0006-03 1 ABPE pudele, 5 l -
Milbeguard Duo 2,5 mg / 25 mg mg V/DCP/23/0051 Ceva Sante Animale', Francija QP54AB51 small dogs; puppies Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 18-Sep-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0051-02 1 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0051-03 2 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0051-04 5 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0051-05 12 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0051-06 24 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0051-07 50 PA/Al/PVH//Al blisteris, 2 tablete -
Milbeguard Duo 12,5 mg / 125 mg mg V/DCP/23/0052 Ceva Sante Animale', Francija QP54AB51 Dogs > 2.5-5 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 18-Sep-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0052-01 1 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0052-02 2 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0052-03 5 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0052-04 12 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0052-05 24 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0052-06 50 PA/Al/PVH//Al blisteris, 2 tablete -
Milbeguard Duo 25 mg / 250 mg mg V/DCP/23/0053 Ceva Sante Animale', Francija QP54AB51 large dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 18-Sep-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0053-01 1 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0053-02 2 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0053-03 5 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0053-04 12 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0053-05 24 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0053-06 50 PA/Al/PVH//Al blisteris, 2 tablete -
Milbeguard Duo 4 mg/10 mg mg V/DCP/23/0054 Ceva Sante Animale', Francija QP54AB51 small cats; kittens Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 18-Sep-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0054-01 1 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0054-02 2 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0054-03 5 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0054-04 12 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0054-05 24 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0054-06 50 PA/Al/PVH//Al blisteris, 2 tablete -
Milbeguard Duo 16 mg / 40 mg mg V/DCP/23/0055 Ceva Sante Animale', Francija QP54AB51 cats weighing at least 2 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale, Francija
Date of authorisation/renewal: 18-Sep-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (18-Sep-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Mar-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0055-01 1 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0055-02 2 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0055-03 5 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0055-04 12 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0055-05 24 PA/Al/PVH//Al blisteris, 2 tablete -
V/DCP/23/0055-06 50 PA/Al/PVH//Al blisteris, 2 tablete -
Reuflogin 50 mg/ml V/NRP/02/1493 Fatro S.p.A., Itālija QM01AB05 horses Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Diclofenac sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1493-01 50 mg/ml 1 Stikla flakons, 50 ml -
Fypryst Combo 50mg/60mg - V/DCP/14/0014 KRKA, d.d., Novo mesto, Slovēnija QP53AX65 ferrets; cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil, S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0014-01 1 Polipropilēna pipete, 1 deva -
V/DCP/14/0014-02 3 Polipropilēna pipete, 1 deva -
V/DCP/14/0014-03 6 Polipropilēna pipete, 1 deva -
V/DCP/14/0014-04 10 Polipropilēna pipete, 1 deva -
Fypryst Combo 67mg/60,3mg - V/DCP/14/0015 KRKA, d.d., Novo mesto, Slovēnija QP53AX65 small dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil, S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0015-01 1 Pipete, 1 deva -
V/DCP/14/0015-02 3 Pipete, 1 deva -
V/DCP/14/0015-03 6 Pipete, 1 deva -
V/DCP/14/0015-04 10 Pipete, 1 deva -
Fypryst Combo 134mg/120,6mg - V/DCP/14/0011 KRKA, d.d., Novo mesto, Slovēnija QP53AX65 medium dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil,S-Methoprene
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0011-01 1 Polipropilēna pipete, 1 deva -
V/DCP/14/0011-02 3 Polipropilēna pipete, 1 deva -
V/DCP/14/0011-03 6 Polipropilēna pipete, 1 deva -
V/DCP/14/0011-04 10 Polipropilēna pipete, 1 deva -

3082 records

© Food and veterinary service · 2026 Cookies policy